Male Volunteers
Showing 1 - 25 of >10,000
Healthy Male Subjects Trial (tafolecimab (a modified manufacturing process), tafolecimab (a original manufacturing process))
Not yet recruiting
- Healthy Male Subjects
- tafolecimab (a modified manufacturing process)
- tafolecimab (a original manufacturing process)
- (no location specified)
Mar 29, 2023
Healthy Trial in Suzhou ([14C]Iruplinalkib (WX-0593))
Completed
- Healthy
- [14C]Iruplinalkib (WX-0593)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 5, 2023
Healthy Volunteers Trial (Liposomal Amikacin for Inhalation)
Completed
- Healthy Volunteers
- Liposomal Amikacin for Inhalation
- (no location specified)
Aug 11, 2023
Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)
Recruiting
- Alzheimer Disease
- GB-5001A
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Nov 17, 2023
Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)
Completed
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Trastuzumab for injection
- Herceptin
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023
Healthy Male Volunteers Trial (HGP1607, HGP1501, HGP1607+HGP1501)
Completed
- Healthy Male Volunteers
- HGP1607
- +2 more
-
Seoul, Korea, Republic ofSeoul Asan Hospital
Nov 7, 2022
Healthy Adult Male Volunteers Trial in Suzhou ([14C]SHR1459)
Active, not recruiting
- Healthy Adult Male Volunteers
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 27, 2022
Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])
Completed
- Gastric Cancer
- +2 more
- Ramucirumab Injection
- Ramucirumab Injection [Cyramza]
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023
Healthy Volunteers Trial in Seoul (Midazolam, Clarithromycin, Grapefruit juice)
Completed
- Healthy Volunteers
- Midazolam
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Healthy Trial in Jeonju (HCP2201, RLD2205, RLD2206)
Not yet recruiting
- Healthy
- HCP2201
- +2 more
-
Jeonju, Jeollabuk-do, Korea, Republic ofChonbuk National University Hospital
Feb 10, 2023
Renal Anemia Trial in Beijing (JT1801 60ug, NESP 60ug)
Recruiting
- Renal Anemia
- JT1801 60ug
- NESP 60ug
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 17, 2023
Systemic Microvascular Reactivity After Ingestion ofEnergy Drink
Completed
- Endothelial Function
- Ingestion of the energy drink (Red Bull®)
- Ingestion of mineral water
-
Rio de Janeiro, Brazil
- +1 more
Oct 11, 2022
Weightlessness Trial in Toulouse (Dry immersion)
Not yet recruiting
- Weightlessness
- Dry immersion
-
Toulouse, FranceMedes-Imps
Aug 5, 2022
Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)
Completed
- Peripheral Analgesic and Anti-itch
-
Suzhou, Jiangsu, Chinaf the First Affiliated Hospital of soochow University
Apr 19, 2023
Healthy Volunteers Trial in Leiden (BIIB115, BIIB115-Matching Placebo)
Recruiting
- Healthy Volunteers
- BIIB115
- BIIB115-Matching Placebo
-
Leiden, NetherlandsCentre For Human Drug Reasearch
Nov 16, 2022
Healthy Trial in Antwerpen (BI 655088, Placebo)
Completed
- Healthy
- BI 655088
- Placebo
-
Edegem, BelgiumSGS Life Science Services - Clinical Research
Apr 20, 2022
Healthy Volunteers Trial in Newark (Bmab 1000, Prolia®)
Recruiting
- Healthy Volunteers
- Bmab 1000
- Prolia®
-
Newark, New JerseyBiotrial Inc
Apr 12, 2022
Mild to Moderate Atopic Dermatitis Trial (IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment, IN-A002 Ointment 0.5% or IN-A002
Not yet recruiting
- Mild to Moderate Atopic Dermatitis
- IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment
- +7 more
- (no location specified)
Feb 6, 2023
Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Ivaltinostat
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 6, 2023
Breast Cancer Trial in Berlin (420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection, Perjeta (EU origin) 420 mg in 14 mL
Recruiting
- Breast Cancer
- 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
- +2 more
-
Berlin, GermanyCRS Clinical Research Services Berlin GmbH
Jul 20, 2022
Healthy Adult Male Volunteers Trial in Verona (Beclomethasone dipropionate)
Completed
- Healthy Adult Male Volunteers
- Beclomethasone dipropionate
-
Verona, ItalyCentro Ricerche Cliniche AOU Integrata di Verona - Policlinico U
May 3, 2022